4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow High Cholesterol: new trials by email Literature Review of High Cholesterol trials Research Report on High Cholesterol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy. Obicetrapib, Placebo - Dyslipidemia, Hypercholesterolemia | Phase 2 | Completed | NewAmsterdam Pharma | 102 | 2022-06-27 | 2024-10-29 |
| Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy Obicetrapib, Ezetimibe 10mg, Obicetrapib placebo - Dyslipidemias, High Cholesterol | Phase 2 | Completed | NewAmsterdam Pharma | 119 | 2022-03-09 | 2024-07-03 |
| Randomized Study of Obicetrapib in Combination With Ezetimibe Obicetrapib 5mg, Ezetimibe 10mg, Placebo - Dyslipidemias, High Cholesterol | Phase 2 | Completed | NewAmsterdam Pharma | 112 | 2021-02-23 | 2024-04-24 |
| Randomized Study of Obicetrapib as an Adjunct to Statin Therapy Obicetrapib - Dyslipidemias, High Cholesterol | Phase 2 | Completed | NewAmsterdam Pharma | 120 | 2021-02-18 | 2024-07-12 |
Dyslipidemias (4) · Hypercholesterolemia (4) · Atherosclerosis (3)
Hyperlipidemias (4) · Lipid Metabolism Disorders (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Arterial Occlusive Diseases (3) · Arteriosclerosis (3) · Cardiovascular Diseases (3) · Vascular Diseases (3)
Ezetimibe (2) · Hypolipidemic Agents (1)
United States (3) · Japan (1) · Netherlands (1)
Marc Ditmarsch (1) · Marc Ditmarsch, MD (1)